OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
March 02, 2020
Can investing in early formulation studies drive a new therapy successfully across the commercialization finish line?
February 28, 2020
Eurofins DiscoverX partners with VelaLabs to enable VelaLabs to perform highly reproducible potency lot release assays under GLP/GMP conditions.
Under the agreement, ERS Genomics will license its gene-editing technology to Aelian Biotechnoloy to support its commercial functional genomic screening platform.
February 12, 2020
Inhalation drug delivery company Vectura announces new organizational structure to drive innovation, customer focus, and growth.
February 06, 2020
Quick approval pathways challenge teams to balance compliance with the need for speed.
Contract partners must help innovators, especially smaller and virtual companies, consider manufacturability as early as possible in development. This requires focusing on technical and operational performance, as well as cost.
February 05, 2020
Catalent builds on its investment in cell and gene therapy development and manufacturing with the acquisition of MaSTherCell Global.
February 03, 2020
In replacing the retiring Paul Hegwood, Ricci Whitlow will oversee global clinical trial operations.
February 02, 2020
Careful design, planning, and record keeping are needed for cleaning and changeover in multiproduct pharmaceutical facilities.
February 01, 2020
How to adopt win-win strategies and understand quality agreements for complying with cGMP when building strategic relationships with pharmaceutical contract research organizations.